This article discusses litigation over the new rule as well as the rule’s changes to prohibit the coverage of treatment for ...

Ikaasa Suri is an MD candidate at the Icahn School of Medicine at Mount Sinai. She graduated with highest departmental honors from the University of California, Los A ...

Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the pod to take a look at recent news that HHS ...

Lisa Fitzpatrick, MD, MPH, MPA, is a board-certified infectious diseases physician and a medical epidemiologist. She began her public health career in 1998 as a member of the Centers for Disease ...

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

Creating clear regulatory frameworks and reimbursement standards can help ensure the responsible and effective integration of ...

One way to save Medicaid money while ensuring that funds are spent to improve staffing and services is to substantially ...

Health Affairs' Rob Lott interviews Cal Chengqi Fang of the University of Chicago about his recent paper that explores how ...

The Medicare prescription drug plan redesign under the Inflation Reduction Act of 2022 aims to simplify the Part D benefit while capping out-of-pocket spending for Part D–covered drugs. Whether ...

By focusing on three priorities—one corresponding to each goal—the Center for Medicare and Medicaid Innovation’s leaders can ...

Dylan Rose Balter is an MD/MHS candidate at the Yale School of Medicine in New Haven, Connecticut.

In the wake of Medicare and Medicaid's 60th anniversary, Health Affairs' Jeff Byers welcomes Jamila Michener of Cornell University to the pod to discuss her recent Forefront article on organized power ...